• 1. Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, P. R. China;
  • 2. Shantou University Medical College, Shantou, 515041, Guangdong, P. R. China;
  • 3. Department of Cardiovascular Surgery, Guangdong General Hospital’s Nanhai Hospital, The Second People’s Hospital of Nanhai District, Foshan, 528251, Guangdong, P. R. China;
GUO Huiming, Email: guohuiming@gdph.org.cn
Export PDF Favorites Scan Get Citation

Objective  To analyze the clinical efficacy and survival outcome of totally thoracoscopic redo mitral valve replacement and evaluate its efficiency and safety. Methods  The clinical data of patients with totally thoracoscopic redo mitral valve replacement in Guangdong Provincial People’s Hospital between 2013 and 2019 were retrospectively analyzed. Survival analysis was performed using the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to determine the risk factors for postoperative death. Results  There were 48 patients including 29 females and 19 males with a median age of 53 (44, 66) years. All the procedures were performed successfully with no conversion to median sternotomy. A total of 15, 10 and 23 patients received surgeries under non-beating heart, beating heart and ventricular fibrillation, respectively. The in-hospital mortality rate was 6.25% (3/48), and the incidence of early postoperative complications was 18.75% (9/48). Thirty-five (72.92%) patients had their tracheal intubation removed within 24 hours after the operation. The 1- and 6-year survival rates were 89.50% (95%CI 81.30%-98.70%) and 82.90% (95%CI 71.50%-96.20%), respectively. Age>65 years was an independent risk factor for postoperative death (P=0.04). Conclusion  Totally thoracoscopic redo mitral valve replacement is safe and reliable, with advantages of rapid recovery, reducing blood transfusion rate, reducing postoperative complications and acceptable long-term survival rate. It is worthy of being widely popularized in the clinic.

Citation: WEI Peijian, LIU Jian, MA Jiexu, CHEN Zhao, ZHANG Yuyuan, TAN Tong, LIU Yanjun, WU Hongxiang, HUANG Huanlei, CHEN Jimei, ZHUANG Jian, GUO Huiming. Clinical efficacy and survival analysis of totally thoracoscopic redo mitral valve replacement. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(5): 731-737. doi: 10.7507/1007-4848.202104012 Copy

  • Previous Article

    Robot-assisted minimally invasive coronary artery bypass in treating multi-vessel coronary artery disease: A retrospective study in a single center
  • Next Article

    Effect of CDM3 on the co-culture of human induced pluripotent stem cells with matrigel-coated polycaprolactone to make cardiac patch